Lindsay Yateman
Family · Lapeer, MINPI 1154913747
Payments from drug & device makers
Across 259 payments — averaging $28.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Coloplast$641
- Dendreon Pharmaceuticals LLC$514
- Merck$459
- Sumitomo Pharma America, Inc.$404
- Pfizer$335
- plus $3K from 31 others
What the payments were for
- Travel & lodging$1,72324%
- Food & beverage$5,45975%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 14 | $2,310 |
| Coloplast | 18 | $641 |
| Dendreon Pharmaceuticals LLC | 14 | $514 |
| Merck | 20 | $459 |
| Sumitomo Pharma America, Inc. | 25 | $404 |
| Pfizer | 17 | $335 |
| Boston Scientific | 12 | $284 |
| Urogen Pharma, Inc. | 13 | $284 |
| Johnson & Johnson(2 entities) | 16 | $277 |
| Accord Healthcare, Inc. | 12 | $219 |
| AbbVie | 11 | $205 |
| Astellas Pharma US Inc | 8 | $150 |
| Sun Pharmaceutical Industries Inc. | 5 | $146 |
| Myriad Genetic Laboratories, Inc. | 8 | $138 |
| Vertex | 5 | $126 |
| Axonics, Inc. | 6 | $101 |
| Progenics Pharmaceuticals, Inc. | 4 | $88 |
| Ferring Pharmaceuticals Inc. | 3 | $64 |
| AstraZeneca | 4 | $62 |
| Tolmar, Inc. | 4 | $61 |
| Endo USA, Inc. | 3 | $47 |
| Bayer | 2 | $44 |
| Agiliti Surgical, Inc. | 2 | $44 |
| Tolmar Pharmaceuticals, Inc. | 2 | $36 |
| Immunitybio, Inc. | 2 | $30 |
| Angiodynamics, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Amgen | 1 | $19 |
| Procept Biorobotics Corporation | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Ambu Inc. | 18 | $17 |
| Halozyme Inc | 1 | $17 |
| Laborie Medical Technologies Corp. | 1 | $15 |
| Blue Earth Diagnostics | 1 | $15 |
| Photocure Inc | 1 | $14 |
| Olympus America Inc. | 1 | $14 |
| Valencia Technologies Corporation | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,267 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 77 | $63,141 |
| MyrbetriqMirabegron | 53 | $36,381 |
| Mirabegron ErMirabegron | 35 | $25,085 |
| Tamsulosin Hcl | 311 | $5,217 |
| Oxybutynin Chloride ErOxybutynin Chloride | 124 | $3,644 |
| Tolterodine Tartrate ErTolterodine Tartrate | 38 | $3,216 |
| Estradiol | 42 | $2,891 |
| Methenamine Hippurate | 40 | $2,814 |
| Trospium Chloride | 25 | $2,406 |
| Finasteride | 121 | $2,233 |
| Cephalexin | 153 | $2,105 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 129 | $1,653 |
| Trimethoprim | 24 | $1,258 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 51 | $1,157 |
| NitrofurantoinNitrofurantoin Macrocrystal | 27 | $863 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $404 | $63,14177 claims |
| Astellas Pharma US IncMyrbetriq | $150 | $36,38153 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Lapeer
- David KocendaLapeer$49K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.